Logo

Eight US Institutions Awarded $350M for Biodefense RCEs

Sep 05, 2003

NEW YORK, Sept. 5 (GenomeWeb News) - US Health and Human Services secretary Tommy Thompson announced yesterday that grants totaling $350 million over five years had been awarded to establish eight Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases at institutions across the country.

 

The National Institute of Allergy and Infectious Diseases will administer the grants, which were awarded to: DukeUniversity, Harvard Medical School, New York State Department of Health, University of Chicago, University of Maryland, University of Texas Medical Branch, University of Washington, and WashingtonUniversity in St. Louis.

 

The grants stipulate that the institutions use genomics, proteomics, and bioinformatics, among other biological methods, to develop methods of dealing with agents of potential bioterrorist attacks - such as anthrax and smallpox - and emerging novel diseases, such as SARS. The institutions must also provide facilities and services in the case of a national biodefense emergency.

 

Proteomics will likely play a large role at the RCEs, as reported in ProteoMonitor last month.

 

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.